Could We Safely Avoid a Second Resection in Selected Patients With T1 Non-Muscle-Invasive Bladder Cancer? Preliminary Results of Cost-Effectiveness Study From HUmanitas New Indications for ReTUR (HuNIRe) Multicenter Prospective Trial.
Front Oncol
; 12: 879399, 2022.
Article
in En
| MEDLINE
| ID: mdl-35664755
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
/
Guideline
/
Health_economic_evaluation
/
Risk_factors_studies
Language:
En
Journal:
Front Oncol
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: